Trials / Active Not Recruiting
Active Not RecruitingNCT07458542
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess real-world effectiveness and safety of oral azacitidine in adults diagnosed with acute myeloid leukemia (AML) in Hong Kong
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azacitidine | According to the product label |
Timeline
- Start date
- 2025-12-09
- Primary completion
- 2026-01-09
- Completion
- 2026-03-31
- First posted
- 2026-03-09
- Last updated
- 2026-03-09
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07458542. Inclusion in this directory is not an endorsement.